Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
Publication year
2019Source
Clinical & Translational Oncology, 21, 6, (2019), pp. 774-780ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Oncology
Tumorimmunology
Surgery
Health Evidence
IQ Healthcare
Journal title
Clinical & Translational Oncology
Volume
vol. 21
Issue
iss. 6
Page start
p. 774
Page end
p. 780
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227881]
- Electronic publications [107344]
- Faculty of Medical Sciences [86219]
- Open Access publications [76465]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.